Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ideal Cures announces a New Manufacturing Location at Sikkim

Mumbai, India, November 14, 2016  Ideal Cures Private Limited is pleased to announce the addition of a fourth manufacturing location at Sikkim in India for supply of its best-in-class products for not only the pharmaceutical and allied industries in the region, but also its expanding customer base globally. Ideal Cures, the first film coating company in the world with all its plants EXCiPACT™ certified, is all set to bring its latest facility, which is presently under construction, on line for supply to the Industry in the first quarter of 2017. This state-of-the art cGMP facility

SSAB’s website highly ranked

SSAB’s web pages providing information about SSAB Group to investors, jobseekers, the media and other stakeholders did well in an international Webranking survey. SSAB’s pages were ranked in joint first place with regard to corporate social responsibility information among both the top 100 large-cap Swedish companies and 50 Finnish companies. The overall ranking was also good – eighth place in Sweden and sixth place in Finland.This was the 20th Webranking conducted by Comprend. The survey evaluated the English-language webpages and social media channels providing corporate information of

Björn Borg designs vintage style sportswear collection for epic Borg movie

Next Autumn, the biographic film Borg is released, a Swedish production about the tennis icon Björn Borg. All sports clothing in the film are developed by the namesake sports fashion brand, once founded by the legend himself. In relation to the film premiere, Björn Borg launches a limited edition collection in an updated vintage style inspired by the film. The name of the collection: Signature.  Borg is a film about how legends were shaped from rivalry, friendship and glamour at a time when everything was possible. It is the story of the revolutionary breakthrough of a Swedish icon,

European study of real-life haemophilia treatment emphasizes need to improve standard of care

Swedish Orphan Biovitrum AB (publ)  (Sobi™) (STO: SOBI) announces the results from a new European study that assessed the efficacy of haemophilia care in real life. The study, which was fully funded by Sobi, showed that treatment practice varied widely between countries and that patients treated on-demand and prophylactically both experienced bleeds, emphasizing the need for further enhancing standard of care. The authors concluded that prophylaxis should be considered for people with frequent bleeds to avoid pain and deterioration of joint function, and the

CLX Communications AB (publ) delivers its first commercial Internet-of-Things (IoT) connectivity application

Stockholm, Sweden - CLX Communications AB (publ.) - a leading provider of cloud based communications solutions announced that the company has made the first deliveries to customers in the rapidly expanding scope of the Internet of Things - IoT. After extensive investments in IoT connectivity service, CLX has started the delivery of commercial solutions to current beta customers. Initially, the deliveries are limited to just a few customers. "We expect to continue to develop the service in close cooperation with our customers and to gradually increase sales of the service." Says CLX CEO

Veidekke ASA: Mandatory notification of trade - Shares purchased by employees in 2016

7,082 employees of Veidekke have received offers to purchase between 50 and 1,000 Veidekke shares each. The employees could choose between two alternatives: Option A with 30 % discount and cash payment and option B with 20 % discount and partial financing. 2,389 employees made use of the offer and subscribed a total of 1.19 million shares during the subscription period from 4 to 11 November. However, there was an oversubscription of 41 % and a reduction was done. After the reduction, the employees were permitted to purchase between 50 and 600 shares each, and a total of 0.84 million

Polygiene expands in new market areas – meet us at Stora Aktiedagen i Göteborg 14th of november 2016

Christian von Uthmann, CEO of Polygiene will talk about Polygiene’s growth story for private investors and the investing interested public at Aktiespararnas Event on the 14th of November. Stora Aktiedagen in Gothenburg is one of the biggest meet-ups for investors in the Nordics, with more than 700 visitors.Polygiene is a marketleader within odor-controll and delivers the function to hundreds of premium brand partners within Sport & Outdoor, allowing them to offer odor-free Sport- & Outdoor garments. Polygiene has added  several new global partner deals during this year in new market

ByggPartner announces its intention to list on Nasdaq First North Premier

For more information, follow the link: http://www.byggpartner.com/1802.phpContacts: Sverker Källgården, CEO, ByggPartner Tel: +46 243 55 95 70 Mob: +46 70 416 97 70 Email: sverker.kallgarden@byggpartner.se Claes Thelander, CFO, ByggPartner Tel: +46 243 55 95 44 Mob: +46 70 419 97 44 Email: claes.thelander@byggpartner.se About ByggPartner ByggPartner is a construction company operating in Stockholm, Mälardalen, Uppsala and Dalarna. In Stockholm, Mälardalen and Uppsala the aim is to further expand and in Dalarna, the Company is one of the leading

Interim Report January - September 2016

Highlights from the past quarter (compared to Q3, 2015) ❏      Increased subscription base from 291,600 to 341,500 subscribers (229,400) ❏      Increased streaming revenues from 111.3 MSEK to 135.7 MSEK (84.0 MSEK) ❏      Increased percentage of foreign sales from 32.4% to 36.0% (29.5 %) ❏      Delivered a positive EBITDA of 19.7 MSEK (1.2 MSEK)CEO’s Comments (Click here to see an interview with CEO Jonas Tellander)  On the first day of the quarter, we finalized our purchase of the publishing group Norstedts. Since

Biohit Oyj unveils groundbreaking GastroPanel® quick test

Biohit Oyj Press Release November 14, 2016 at 9:30 am local time (EET) GastroPanel® quick test can be performed during a clinical appointment from a fingertip blood drop. The new test is an advanced version of Biohit´s unique GastroPanel® stomach health test. GastroPanel® quick test differs from the current clinical test version by giving the results immediately during a single clinical appointment. The GastroPanel® quick test saves costs and unnecessary clinical appointments as well as speeds up the referral to further examinations and eventual treatment, which significantly improves

C-RAD AB – Interim report July-September 2016

Key events in the period July-September 2016 · Net sales: Jul-Sep 22.5 (15.4) MSEK, +46% · Rolling 12m 75.5 (64.3) MSEK +17% · Order intake: Jul-Sep 28.2 (23) MSEK, +23% · Rolling 12m 98.3 (86.1) MSEK +14% · Operating loss: Jul-Sep -7.9 (-7.0) MSEK · Net results per share: Jul-Sep -0.29 (-0.33) · Bill Dowd appointed president of US subsidiary C-RAD Inc. · Lars Nyberg was elected as new Member of the Board and as Chairman of C-RAD. · First order from Belgium for C-RAD systems, order value 6.1 MSEK.           Comments from Tim Thurn, CEO: Record order

Invitation to Stora Enso’s Capital Markets Day webcast

Stora Enso will arrange a Capital Markets Day in London on 17 November 2016. You are welcome to follow the presentations focusing on Stora Enso’s strategy, performance, and biomaterials and wood products businesses in a live webcast at http://edge.media-server.com/m/p/ddmehd62. The webcast will run between 13.00 and 15.00 UK time with the following programme: 1. Welcoming words, Ulla Paajanen-Sainio, SVP Investor Relations, Moderator for the CMD 2. Transformation strategy – CEO Karl-Henrik Sundström 3. Biomaterials – Juan Carlos Bueno, EVP, Biomaterials 4. Wood Products – Jari

Addition to Press Release: C-RAD receives the first two orders from General Electric

C-RAD has issued a press release on November 9, 2016 announcing the two first orders from General Electric. C-RAD want to add an information that delivery for the systems is expected to happen during the fourth quarter.   Please see the original press release as published on November 9, 2016 below:   C-RAD has received the first order for two Sentinel 4DCT systems from General Electric. The systems are ordered for customers in Europe. The total order value is approximately 1 MSEK.   C-RAD and GE Healthcare have entered a sales and distribution agreement for Sentinel 4DCT™

Mandatory notification of trade in Cxense ASA

Reference is made to the announcement 14 November 2016 from Cxense ASA ("Cxense" or the "Company") regarding the completion of the warrants exercise period. Each warrant gave the holder the right to subscribe for one (1) share in the Company. Five (5) primary insiders in Cxense have exercised warrants and subscribed for shares in Cxense. Morten Opstad (Chairman of the Board of Directors in Cxense) has, through his company Marc O Polo Norge AS, subscribed for 1,000 shares. Morten Opstad will, after completion of the warrant exercise, own or control 11,829 shares in Cxense. Svein

Experienced Games Industry Veteran Kim Nordström Joins Paradox Interactive

Former General Manager of King in Malmö Appointed to Run Innovation & MobileSTOCKHOLM — Nov. 14, 2016 — Global publisher and developer Paradox Interactive today revealed that experienced game veteran Kim Nordström will be joining its ranks to take lead on the company's innovation and mobile initiatives. Kim has more than 15 years of experience from the games industry in various roles and capacities, most recently as General Manager of King in Malmö and previously as R&D Manager at SCEA (PlayStation) in San Francisco developing PlayStation 4. He will assume the role in January when he will

Etrion Announces Agreement to Sell Italian Solar Portfolio to Ultor for Total Cash Consideration of up to Euro 102 Million

November 14, 2016, Miami, Florida, United States – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, today announced the signing of a definitive sale and purchase agreement with Ultor S.p.A (“Ultor”), a joint venture owned equally by Enel Green Power S.p.A. and Fondo Italiano per le Infrastrutture “F2i”. Ultor is purchasing Etrion’s 60-megawatt (“MW”) Italian solar portfolio for initial cash consideration of Euro 78 million and the assumption of related project-level debt of Euro 221 million, with potential additional cash earn-out

Interim report January - September 2016

Third quarter 2016 · Revenues for the third quarter amounted to SEK 127.2 (90.5) million, an increase by 41 % compared to the same period last year. · Operating profit amounted to SEK 54.6 (32.0) million, an increase by 71 %. · Profit before tax amounted to SEK 54.6 (32.0) million, and profit after tax amounted to SEK 42.3 (24.8) million. · Cash flow from operating activities amounted to SEK 102.7 (53.8) million, and cash flow from investing activities amounted to SEK -30.8 (-39.6) million. · By the end of the period cash and short term placements amounted to SEK 215.1 (190.

Nordic Capital-backed Lindorff to combine with Intrum Justitia, creating the industry’s leading provider of credit management services

Not for distribution in or into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful. Press release, November 14, 2016 Nordic Capital-backed Lindorff to combine with Intrum Justitia, creating the industry’s leading provider of credit management services -        Continued high activity in 2016 for the Nordic Capital Funds Nordic Capital Fund VIII-owned Lindorff and Intrum Justitia have announced their intention to combine to create the industry’s leading provider of credit management services ("CMS"). The combined

GE Aviation declares its recommended public cash offer to the shareholders of Arcam unconditional and will complete the offer

Stockholm, November 14, 2016. GE Sweden Holdings AB (“GE”), a Swedish company within the GE Aviation operating unit and an indirectly wholly-owned subsidiary of General Electric Company[1], announces that all conditions for completion of its recommended public cash offer (the “Offer”) to acquire all ordinary shares[2] in Arcam Aktiebolag (publ) (“Arcam”) for a consideration of SEK 300 per ordinary share in cash have been satisfied or waived. GE declares the Offer unconditional and will complete the Offer. The ordinary shares in Arcam tendered during the extended acceptance period of the

Completion of Warrants exercise period

Reference is made to previous stock exchange announcements from Cxense ASA ("Cxense" or the "Company") concerning exercise of  warrants (ISIN NO 001 0747454). The subscription period for exercising the warrants ended on Saturday, 12 November 2016. 82.7% of the 475,000 warrants have been subscribed for by the warrant holders. Payment for the new shares will fall due on 25 November 2016. The new shares may not be transferred or traded before they are fully paid and the share capital increase pertaining to the warrants has been registered with the Norwegian Register of Business

Notice of Extraordinary General Meeting of the shareholders in Intrum Justitia AB (publ)

The shareholders of Intrum Justitia AB (publ) are hereby summoned to an Extraordinary General Meeting on Wednesday 14 December 2016, at 10 a.m. at the Company’s premises, Hesselmanstorg 14 in Nacka, Stockholm, Sweden. Coffee is served from 9.30 a.m.Participation Shareholders who wish to attend the General Meeting shall both                 be entered in the company’s register of shareholders kept by Euroclear Sweden AB (not nominee-registered) by Thursday, 8 December 2016 and                  notify their intention to attend the meeting by Thursday, 8 December 2016 at the latest.

Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Phase 3 Results for Long-acting Buprenorphine for Treatment of Opioid Addiction

· Head-to-head study of CAM2038 versus daily sublingual buprenorphine · CAM2038 met both FDA and EMA primary endpoints of non-inferiority (p<0.001) · CAM2038 demonstrated statistical superiority for the key secondary endpoint (p=0.004) · Robust clinical data to support MAA and NDA submissions in mid-2017 · The CAM2038 development program targets an urgent and growing opioid crisis in the US and globallyPrinceton, New Jersey and Lund, Sweden — 14 November 2016 — Braeburn Pharmaceuticals and Camurus (NASDAQ STO: CAMX) are pleased to announce positive top-line results from a

Wilson Therapeutics’ Nomination Committee appointed

In accordance with the decision of the Annual General Meeting on 4 April 2016, Wilson Therapeutics’ Nomination Committee for the AGM 2017 shall comprise the Chairman of the Board and one representative for each of the three largest shareholders based on ownership of the Company as per the end of September 2016. Accordingly, the following committee members have been appointed: · Andrew Kay, Chairman of the Board · Staffan Lindstrand, representing HealthCap · Sarah Shackelton, representing Abingworth · Thomas Casdagli, representing MVM. The Nomination Committee has

There are no items matching the current filter
There are no more items matching the current filter
Back to top